Earnings call transcript: Sono-Tek misses Q2 2027 estimates as shares fall 11%

Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

Original reporting
Published Oct 14, 2026, 4:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 4:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$SOTK
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

High
01

Why it matters

The earnings miss triggered an 11% pre‑market decline, highlighting investor sensitivity to guidance in small‑cap industrial stocks.

02

Market read

The report is a primary earnings disclosure for a micro‑cap, offering a timely trading signal.

03

What to watch

Cash position is robust and capacity expansion plans may unlock higher revenue in FY2028, which the market may undervalue.

Relevance 6/10Novelty 8/10Timing: pre‑market today

Background

Sono-Tek Corp. (SNTE) provides ultrasonic coating systems for medical and alternative‑energy applications.

Market effects

Small‑cap industrial and medical‑device coating segment may see heightened scrutiny on growth forecasts.

US small‑cap equities could experience modest pullback on earnings disappointment.

Limited to niche ultrasonic coating market; no broad macro effect.

Counterpoint

Despite the miss, the strong backlog and margin expansion could support a rebound if guidance improves.

Key entities

  • Sono‑Tek Corp.

    Manufacturer of ultrasonic coating systems.

Related articles

$SOTKMed

Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales

$SOTKMed

Sono-Tek stock rises on record $3.6M production line order

Sono-Tek Corp (NASDAQ:SOTK) shares rose 3.9% premarket after the company said it received a $3.6 million order for an integrated advanced manufacturing production line for medical diagnostic device coating. Sono-Tek said it is its largest single-line order, placed by an existing customer moving to high-volume manufacturing, with shipment expected in fiscal 2028.

$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

$SOTKMed

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.